Panic Disorder
213
20
27
132
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
28 trials with published results (13%)
Research Maturity
132 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.0%
15 terminated out of 213 trials
89.8%
+3.3% vs benchmark
19%
40 trials in Phase 3/4
21%
28 of 132 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 132 completed trials
Clinical Trials (213)
Serotonin Variants & Gut Microbiota in Mental Health
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
Efficacy and Safety of HB-1 for Panic Disorder
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders
Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy
LHC-CIDI-5 in Hong Kong
The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder
IL-33, sST2, and CRP in Panic Disorder
Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance and Interoception in Healthy Individuals and Panic Disorder.
Level of Physical Activity and Fear Learning
Qigong and Multicomponent Exercise in Panic Disorder
Stepped Versus Stratified Care for Anxiety Disorders in Youth
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
α-N-acetylgalactosaminidase Levels in Panic Disorder